Clark M A, Humphrey S J, Smith M P, Ludens J H
Cardiovascular Diseases Research, Upjohn Laboratories, Kalamazoo, Michigan.
J Pharmacol Exp Ther. 1993 May;265(2):933-7.
Small-conductance, ATP-sensitive K(+)-channels (KATP) localized in apical membranes of both thick ascending limb of the loop of Henle and cortical collecting duct cells may be involved in Na+ reabsorption and K+ secretion in the mammalian kidney. Possible pharmacologic tools to evaluate such an hypothesis may be the antidiabetic sulfonylureas which block K(+)-channels in pancreatic beta-cells. In saline-loaded conscious rats, glyburide (GLY) dose-dependently increased urinary Na+ excretion with little change in urinary K+ excretion after i.p. administration (10-100 mg/kg). In renal clearance studies, GLY at 25 mg/kg i.v. increased Na+ excretion 350% during the first hour post-treatment without affecting K+ excretion, glomerular filtration rate, mean arterial pressure or heart rate. GLY at 50 mg/kg was no more natriuretic than the 25 mg/kg dose, whereas 12.5 mg/kg of GLY increased Na+ excretion 200%. The change in Na+ excretion produced by 25 mg/kg of GLY in streptozotocin-induced diabetic rats was significantly greater than the change after drug vehicle in these animals. It is unlikely that the natriuresis produced by GLY is secondary to changes in plasma insulin and/or glucose because the doses used were far above GLY's insulin-releasing action (i.e., all natriuretic doses would have produced maximal insulin release) and GLY was natriuretic in streptozotocin-induced diabetic rats. It is possible that GLY interferes with reabsorption of Na+ by blocking KATP and thereby interrupting K+ recycling and Na(+)-2Cl(-)-K+ cotransport in the loop of Henle.
定位在髓袢升支粗段和皮质集合管细胞顶端膜上的小电导ATP敏感性钾通道(KATP)可能参与哺乳动物肾脏的钠重吸收和钾分泌。评估这一假说的可能药理学工具或许是抗糖尿病磺脲类药物,其可阻断胰腺β细胞中的钾通道。在生理盐水负荷的清醒大鼠中,腹腔注射格列本脲(GLY,10 - 100 mg/kg)后,尿钠排泄量呈剂量依赖性增加,而尿钾排泄量变化不大。在肾脏清除率研究中,静脉注射25 mg/kg的GLY在治疗后的第一小时内使钠排泄量增加了350%,而不影响钾排泄、肾小球滤过率、平均动脉压或心率。50 mg/kg的GLY的利钠作用并不比25 mg/kg剂量更强,而12.5 mg/kg的GLY使钠排泄量增加了200%。链脲佐菌素诱导的糖尿病大鼠中,25 mg/kg的GLY引起的钠排泄变化显著大于这些动物注射药物赋形剂后的变化。GLY产生的利钠作用不太可能继发于血浆胰岛素和/或葡萄糖的变化,因为所用剂量远高于GLY的胰岛素释放作用(即所有利钠剂量都会产生最大胰岛素释放),并且GLY在链脲佐菌素诱导的糖尿病大鼠中具有利钠作用。GLY可能通过阻断KATP干扰钠的重吸收,从而中断髓袢中的钾循环和Na(+)-2Cl(-)-K+共转运。